Is subretinal surgery feasible for a non-responsive juxtafoveal type 2 choroidal neovascular membrane?

To describe the long-term outcome of a patient with multifocal choroiditis, who underwent surgical removal of a type 2 choroidal neovascular membrane employing 23 G pars plana vitrectomy. A 50-year-old man was treated with 3 monthly intravitreal bevacizumab injections, but despite treatment, visual...

Full description

Saved in:
Bibliographic Details
Published in:American journal of ophthalmology case reports 2019-09, Vol.15, p.100460, Article 100460
Main Authors: Quiroz-Mercado, Hugo, Lisker-Cervantes, Andrés, Arroyo, Luis, Mandava, Naresh, Siringo, Frank S, Paciuc-Beja, Miguel, Gonzalez-Salinas, Roberto
Format: Article
Language:English
Subjects:
Case Report
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To describe the long-term outcome of a patient with multifocal choroiditis, who underwent surgical removal of a type 2 choroidal neovascular membrane employing 23 G pars plana vitrectomy. A 50-year-old man was treated with 3 monthly intravitreal bevacizumab injections, but despite treatment, visual acuity continued to worsen from 20/40 to 20/100, and bleeding was not receding. A minimal invasive pars plana vitrectomy was performed for surgical removal of the neovascular complex without any complicating incident. Subsequent visual acuity was 20/25 for more than eleven years. Surgical removal of choroidal neovascular membranes employing minimal invasive surgery in addition to anti-VEGF therapy, and OCT evaluation can be a viable approach for selected cases of juxtafoveal type 2 CNV.
ISSN:2451-9936
2451-9936
DOI:10.1016/j.ajoc.2019.100460